Is Cipher Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Cipher Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $1.340, you would have made a profit of $16.61 per share or 1 239.55%
No, the average daily trading liquidity for Cipher Pharmaceuticals is $47 270 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Cipher Pharmaceuticals has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 42.63, the company's ability to pay off the debt is good. Cipher Pharmaceuticals has a very good net profit margin of 102.43% and should have very high tolerances against inflation.
We have calculated the inflation risk for Cipher Pharmaceuticals to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.